Dr. Reddy's launches generic Zemplar; Legislation would limit use of guns by FDA agents;

> Two senior Republican lawmakers have come out in favor of opposition by the generic drug industry to a proposed FDA rule that would have them change labels on products if they receive new safety information. Story

> The FDA has approved Dr. Reddy's generic version of Zemplar, the active version of vitamin D made by AbbVie ($ABBV). Story

> Michigan is looking at legislation to regulate compounding pharmacies. Item

> Oasmia Pharmaceutical AB has extended a production collaboration with Baxter's ($BAX) BioPharma Solutions for the Swedish pharmaceutical company products. Release

> The Philippines FDA has ordered the recall of all lots of a heparin-based blood thinner manufactured in India. Report

> The EU will require a new logo on all authorized online pharmacies that will link to a database of approved pharmacies to help consumers avoid counterfeits. Story

And Finally... Representative Chris Stewart (R-UT) is introducing legislation that would limit the use of guns by agents in departments like the FDA, saying they don't need to be "armed to the teeth." Story